The International Society of Cellular Therapy (ISCT) believes that the massive and unprecedented budget cuts to US governmental scientific agencies including the (National Institutes of Health (NIH) and National Science Foundation (NSF) proposed by US President Donald Trump, if implemented, will have wide ranging and potentially life threaten in ramifications to science, clinical care and patients in the US and internationally.
ISCT president, Dr Catherine Bollard, states that the ISCT global leadership representing all stakeholders involved in cell therapy around the world believes many of the cuts proposed for the NIH by the Trump administration will directly and dangerously impact the entire international cell therapy, medical and scientific communities.
Dr Bollard highlights the example of the proposed elimination of the Fogarty International Center for Advanced Study in the Health Sciences, the NIH program promoting and funding medical research and training outside the USA. Since the late 1960s, the Center has been instrumental in bringing together the international medical and scientific communities to address global health issues such as HIV/AIDS and Ebola.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze